Dr. Bryce Carl Rhodehouse, DO

Dr. Rhodehouse practices at Mountain View Hospital in Idaho Falls, Idaho, part of Intermountain Health.

Dr. Rhodehouse's NPI, 1659809630, was assigned on June 2, 2017. Dr. Rhodehouse graduated from Des Moines University in 2017. Dr. Rhodehouse holds Texas license R8656.

Dr. Rhodehouse's primary practice is Mountain View Hospital, at 2325 Coronado Street, Idaho Falls, ID 83404 in Bonneville County. The practice phone is (208) 557-2700.

Dr. Rhodehouse's primary practice is Mountain View Hospital in Idaho Falls, Idaho, part of Intermountain Health. Dr. Rhodehouse is also affiliated with Eastern Idaho Regional Medical Center. The medical group on file is Mountain View Hospital. Dmand AI also links Dr. Rhodehouse to 3 more hospitals and 1 medical group, each named with a free account. Dr. Rhodehouse's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rhodehouse practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Rhodehouse's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rhodehouse is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Rhodehouse is licensed in Texas.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart failure, heart valve disorders, high cholesterol, intermittent racing heartbeat (PSVT) and obesity among the conditions Dr. Rhodehouse treats.

CMS data shows 2,528 Medicare services from Dr. Rhodehouse across 21 procedure codes in 2024, for 1,204 Medicare patients. Medicare paid $114,847 for them.

CMS counts 1,204 Medicare patients who saw Dr. Rhodehouse in 2024. The largest group is 75 to 84, with 494 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rhodehouse's median patient age at 75, with 48% women.

In 2024, Dr. Rhodehouse wrote 1,782 Medicare Part D claims for 358 patients. 78% of them were for generic drugs. CMS names the drug for 1,608 of them, across 31 drugs with 11 or more claims each, at $338,649 in total drug cost. In 2023, CMS named 428 claims across 17 drugs.

Dr. Rhodehouse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Rhodehouse, published from 2013 to 2023. The most frequent topics are Hyperhomocysteinemia and Mice, Inbred C57BL. Dr. Rhodehouse has published most often in Proc (Bayl Univ Med Cent). Dr. Rhodehouse's most frequent co-authors are Jerry D. Fan, MD, Tayler Acton, DO and Kadilee Adams, DO.

CMS Open Payments shows 65 general payments to Dr. Rhodehouse from 17 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 46% of the total. Abbott Laboratories paid the most, $1,564.

Dr. Rhodehouse graduated from Des Moines University in 2017.

Dr. Rhodehouse is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.